Leadiant Biosciences, Inc.

September 8, 2026 A $20M settlement ends a lawsuit that claimed VSL Pharmaceuticals marketed and sold reformulated VSL#3 as the original, clinically tested product.

July 26, 2019 Probiotic product VSL#3 is at the center of a proposed class action out of Maryland that claims VSL Pharmaceuticals, Inc. deceived consumers by passing off a cheaper, less effective formulation as the original product.